Ignite Creation Date:
2024-05-06 @ 6:01 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05513040
Status:
RECRUITING
Last Update Posted:
2022-09-02
First Post:
2022-08-21
Brief Title:
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
Sponsor:
Air Force Military Medical University China
Organization:
Air Force Military Medical University China
Study Overview
Official Title:
Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Functional dyspepsia FD is one of most common chronic gastrointestinal disorders Several types of drugs were demonstrated to be effective in reduction or remission of symptoms and severity of FD including proton pump inhibitors PPI Tricyclic antidepressant and prokinetics However the clinical course of FD after taking medication-based treatment was unknown Furthermore 20-50 patients remained persistent or worsening of dyspepsia symptoms after treatment Previous studies have suggested psychological factors eg anxiety sleep disturbance were related to less improvement of symptoms in natural clinical course However there is limited evidence in terms of clinical and psychological factors for less improvement in patients receiving medication treatment for dyspepsia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None